Boosted Labs Research Blog

Triple receptor agonist (GLP-1, GIP & glucagon). Phase 2 trials report up to 24% body weight reduction — the most potent fat loss compound in research.

GH-derived lipolytic fragment. Stimulates fat breakdown and inhibits lipogenesis without affecting glucose metabolism or growth pathways. TGA-studied in Australia.

Semaglutide-based GLP-1 receptor agonist. STEP trials demonstrated ~15% mean body weight reduction. Most extensively studied anti-obesity compound available.

Tirzepatide dual GLP-1/GIP agonist. SURMOUNT trials report up to 22.5% body weight reduction — superior outcomes vs GLP-1 alone across metabolic markers.

Dual repair blend combining BPC-157’s angiogenic/tissue-healing properties with TB-500’s actin dynamics and cell migration effects. Studied for tendon and soft-tissue recovery.

Tripeptide derived from alpha-MSH. Studied for potent anti-inflammatory properties in gut mucosa, skin, and systemic inflammation research models.

Selective GH secretagogue with no cortisol or prolactin elevation. Most studied compound for clean GH pulse amplification and body composition research.

Synergistic GHRH + secretagogue combination. Extends GH pulse duration and amplitude simultaneously — widely studied for lean mass and body composition research.

Long-acting GHRH analogue with Drug Affinity Complex. Clinical trials show dose-dependent GH increases lasting 6–8 days post-administration.

HPG axis regulator. Human trials demonstrate dose-dependent LH surges and testosterone elevation — studied for male hormonal support and reproductive research.

Human chorionic gonadotropin. Researched for LH-mimetic activity, testicular function support, and hormonal axis studies in male endocrine research.

FDA-approved GHRH analogue (Egrifta). Specific research focus on visceral adipose tissue reduction via IGF-1 pathway stimulation, particularly in metabolically compromised models.

Mitochondria-derived peptide. AMPK activator that mimics exercise adaptations — improves insulin sensitivity, fat oxidation, and metabolic flexibility in Cell Metabolism-published research.

Mitochondria-targeted antioxidant. Concentrates within the inner mitochondrial membrane, reduces ROS, restores bioenergetics in aged and metabolically compromised tissue.

Nicotinamide adenine dinucleotide — essential coenzyme for sirtuin activation, DNA repair, and cellular energy. NAD+ levels decline ~50% by age 60. One of the most-studied longevity compounds.

Tetrapeptide that stimulates telomerase activity. Russian long-term studies show telomere elongation in aged tissue, pineal gland melatonin regulation, and life extension in animal models.

Copper tripeptide complex. Regulates 4,000+ genes, stimulates collagen synthesis, promotes wound repair, and reduces inflammation through TGF-β pathway modulation.

Synthetic analogue of alpha-MSH. Studied for melanocyte stimulation, UV-independent skin tanning, and melanocortin receptor activity research.

ACTH-derived neuropeptide. Studied for BDNF upregulation, cognitive enhancement, neuroprotection after ischaemia, and anxiolytic effects in Russian clinical research spanning 30+ years.

Tuftsin analogue with anxiolytic and nootropic properties. Studied for GABAergic modulation, anxiety reduction, and memory enhancement without sedation or dependence risk.

Delta Sleep-Inducing Peptide. Studied for slow-wave sleep promotion, LH and GH regulation, stress response modulation, and neuroendocrine balance in sleep research.